P/E ratio for Neogen (NEOG)

P/E ratio history for Neogen from 2001 to 2023

PE ratio at the end of each year

P/E ratio for similar companies or competitors

Company	P/E ratio	P/E ratio differencediff.	Country
PerkinElmer PKI	15.0	-112.24%	🇺🇸 USA
IDEXX Laboratories IDXX	42.3	-134.62%	🇺🇸 USA
Illumina ILMN	-5.10	-95.83%	🇺🇸 USA
Pacific Biosciences PACB	-1.30	-98.94%	🇺🇸 USA
Meridian Bioscience VIVO	35.0	-128.64%	🇺🇸 USA
Thermo Fisher Scientific TMO	33.5	-127.42%	🇺🇸 USA
Danaher DHR	28.8	-123.52%	🇺🇸 USA
Becton Dickinson BDX	40.8	-133.38%	🇺🇸 USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.